2023; 21(4): 742-748  https://doi.org/10.9758/cpn.23.1050
Relationship between Loudness Dependence of Auditory-evoked Potentials and Suicidality
Youngjun Cho1, Young-Min Park1, Miseon Shim2, Seung-Hwan Lee1
1Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea
2Institute of Industrial Technology, Korea University, Sejong, Korea
Correspondence to: Young-Min Park
Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine, 170 Juhwa-ro, Ilsanseo-gu, Goyang 10380, Korea
E-mail: medipark@daum.net
ORCID: https://orcid.org/0000-0002-4993-1426
Received: January 4, 2023; Revised: March 8, 2023; Accepted: March 13, 2023; Published online: May 18, 2023.
© The Korean College of Neuropsychopharmacology. All rights reserved.

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Objective: Serotonin concentration is associated with suicide in patients with major depressive disorder. Loudness dependence of auditory-evoked potentials (LDAEPs), a representative neurophysiological indicator, is related to serotonin activity. Therefore, this study aimed to investigate the relationship between LDAEPs and suicidal ideation, suicide attempts, and the severity of depression.
Methods: We evaluated the scalp N1, P2, and N1/P2 LDAEPs along with standardized low-resolution brain electromagnetic tomography (sLORETA)-localized N1, P2, and N1/P2 LDAEPs of 221 patients with major depressive disorder. The demographic and clinical data of the patients, including data on suicidal ideation and previous suicide attempts, were obtained from clinical interviews and medical records. The severity of depression was assessed using the Beck Depression Inventory and Hamilton Depression Rating Scale, whereas suicidal ideation was evaluated using the Beck Scale for Suicidal Ideation (BSS).
Results: The total BSS score was associated with low N1/P2 LDAEP (p = 0.045), whereas P2 sLORETA-LDAEP was associated with lower previous suicide attempts (p = 0.043). In addition, suicide attempt was correlated with an elevated P2 left sLORETA-LDAEP (coefficient = 4.638, p = 0.038).
Conclusion: These findings suggest that suicidal ideation is associated with decreased LDAEP, whereas suicide attempt is associated with increased LDAEP.
Keywords: Evoked potentials, auditory; Major depressive disorder; Serotonin; Suicide
INTRODUCTION

Major depressive disorder is a mental health condition characterized by depressed mood and diminished interest, causing various mental and physical symptoms such as decreased appetite and concentration. These symptoms impair daily functions, including social and occupational functions. The World Health Organization reported that 280 million people worldwide suffer from depression, and that more than 700,000 individuals commit suicide each year as a result of depression [1]. Therefore, attempts have been made to predict and prevent suicide in patients with depression.

Serotonin concentration is associated with suicide in patients with major depressive disorder [2]. People who attempt suicide have been found to have lower levels of serotonin metabolites in their cerebrospinal fluid [3]. However, there are limitations to using results of cerebrospinal fluid tests to predict suicide in a clinical setting. Thus, some studies have been conducted to investigate the use of loudness dependence of auditory-evoked potentials (LDAEPs) as an alternative to measuring serotonin activity in the cerebrospinal fluid in clinical practice. LDAEP, a representative neurophysiological indicator, is related to serotonin activity [4] and is expected to be suitable for the classification of depression subtypes, evaluation of depression severity, exploration of psychopathology, and prediction of treatment responsiveness [5-8]. However, the association between LDAEPs and suicidality is unclear [9]. This is because there are limited studies on LDAEPs and suicidality. In addition, the number of participants included in the existing studies has not been large enough to yield significant evidence. The aim of this study was to investigate the relationship between LDAEPs and suicidal ideation or suicide attempts in a large group of patients with depression.

METHODS

Study Design and Participants

This was a retrospective study of psychiatric outpatients aged 16−74 years who were diagnosed with major depressive disorder using the Diagnostic and Statistical Manual of Mental Disorders 5th edition criteria at Inje Paik Hospital from 2014 to 2021. The demographic and clinical data of the patients, including data on suicidal ideation and previous suicide attempts, were obtained from clinical interviews and medical records. The Beck Depression Inventory (BDI) [10] and Hamilton Depres-sion Rating Scale (HAMD) [11] were used to assess the severity of depression. The Barratt Impulsiveness Scale (BIS) [12], Hamilton Anxiety Rating Scale (HAMA) [13], and Beck Scale for Suicidal Ideation (BSS) [14] were used for the evaluation of impulsiveness, anxiety, and suicidal ideation, respectively. The BDI is a valid instrument used to determine the severity of self-reported depression. The HAMD is a scale commonly used for the evaluation of depression. The BIS is a frequently used self-report scale that measures several dimensions of impulse control. The HAMA is a scale used for rating the severity of anxiety, and the BSS is a self-report scale used to assess suicidal ideation. The protocol of this study was approved by the Ethics Committee of Inje University Ilsan Paik Hospital (ISPAIK 2022-09-043).

Electroencephalography Methods

Each patient was seated in a quiet room in a comfortable chair. The auditory stimulation consisted of 1,000 stimuli with interstimulus intervals ranging from 500 to 900 ms. Using headphones (MDR-D777; Sony), randomized tones of 1,000 Hz were presented at five intensities (55-, 65-, 75-, 85-, and 95-dB sound pressure levels) for 80 ms. The stimuli were created using the E-Prime software (Psychology Software Tools). The electroencephalo-graphy (EEG) data were collected from 64 scalp sites fitted with silver/silver-chloride electrodes using an Auditory Neuroscan NuAmp amplifier (Compumedics USA), in accordance with the international 10−20 system (imped-ance < 10 kO). Data were collected at 1,000 Hz sampling rate with a bandpass filter ranging from 0.5 to 100 Hz. In addition, both the horizontal and vertical electrooculograms were measured using four electrodes. The peak-to- peak N1/P2 amplitudes for the five stimulus intensities were calculated, and the LDAEP was calculated as the slope of the linear regression curve.

In addition to EEG, sLORETA was performed to estimate the current density [15]. We calculated the three values of current density for the left, right, and averaged data from both hemispheres over the primary auditory cortex. The slope of the linear regression curve of the current density of BA41 for the five stimulus intensities was used to calculate the source LDAEP.

Statistical Analyses

All statistical analyses were performed using Statistical Package for Social Sciences (version 25; IBM Co.). The demographic, psychopathological, and LDAEP data of the patients were compared using correlation analysis (Spearman’s correlation) and Student’s ttest. Multivariate linear regression analyses were conducted to identify the association between age, gender, suicidal ideation, previous suicide attempts, depression severity, and each LDAEP. Binary logistic regression analysis was performed to determine whether the LDAEP is associated with a history of suicide attempts.

RESULTS

A total of 221 patients were included in this study. The distributions of demographic characteristics; total BDI, HAMD, BIS, HAMA scores and scalp and standardized low- resolution brain electromagnetic tomography (sLORETA)- derived LDAEPs of the patients are outlined in Table 1 according to the presence or absence of a history of suicide attempts. There were significant differences in age, BDI score, BSS score, and HAMD score between patients with and without a history of suicide attempts; however, there were no significant differences in variables, including LDAEP. The average age of patients without a history of suicide attempts was higher than that of patients with a history of suicide attempts (t = 2.295, p = 0.023). The proportion of patients with a history of alcohol consumption was significantly higher in the group with a history of suicide attempts than in the group without a history of suicide attempts (χ2 = 17.761, p < 0.001). The total BDI score of the group with a history of suicide attempts was higher than that of the group without a history of suicide attempts (t = −3.17, p = 0.002). In addition, the total BSS score of the group with a history of suicide attempts was higher than that of the group without a history of suicide attempts (t = −6.62, p < 0.0001). However, the total HAMD score of the group without a history of suicide attempts was higher than that of the group with a history of suicide attempts (t = 3.31, p = 0.001).

The results showed that total BSS score was negatively correlated with N1/P2 LDAEP (r = 0.221, p = 0.028) (Fig. 1). Linear regression analysis conducted using history of alcohol consumption and sex as covariates showed that an elevated N1/P2 LDAEP was associated with a low total BSS score (t = −2.015, p = 0.045), whereas a history of alcohol consumption was associated with a high total BSS score (t = 2.963, p = 0.003) (Table 2). This indicated that increased serotonergic activity was associated with an increased likelihood of suicidal ideation.

Linear regression analysis conducted using BDI, BSS, and HAMA scores; age; and sex as covariates showed that an elevated P2 sLORETA-LDAEP was associated with a low BDI score (t = −2.533, p = 0.012), a high number of previous suicide attempts (t = 2.037, p = 0.043), and female sex (t = 2.556, p = 0.011) (Table 3). This indicated that having a history of suicidal ideation is associated with decreased serotonergic activity.

Multiple binary logistic regression analysis of the presence or absence of a history of suicide attempts showed that a history of suicide attempts was associated with an elevated P2 left sLORETA-LDAEP (coefficient = 4.638, p = 0.038), a low total HAMA score (coefficient = −0.077, p = 0.031), and high total BSS and BDI scores (coefficient = 0.005, p = 0.040) (Table 4). This indicated that patients who had previously attempted suicide had lower serotonergic activity than those without a history of suicide attempts. In addition, individuals with severe depression and suicidal ideation had an increased probability of a history of suicide attempts.

DISCUSSION

In this study, we investigated the relationship between LDAEPs and suicidality and the severity of depression in a large group of patients with major depressive disorder. The initial results, without controlling for variables, showed that LDAEPs were not significantly associated with the presence or absence of a history of suicide attempts. However, linear regression and binary logistic regression analyses showed that high LDAEPs were associated with a history of suicide attempts. In addition, the results showed that the severity of suicidal ideation and depression increased as LDAEPs decreased. Patients with a history of suicide attempts, on the other hand, had higher LDAEPs than those without a history of suicide attempts. In the group with past suicide attempts, the BDI score was higher, but the HAMD score was significantly lower. Because previous suicide attempt in this study is a self-reported history, it is assumed that the suicide attempt group has a stronger correlation with BDI than with HAMD, the objective scale. When only BDI item 9 and HAMD item 3, each representing suicidal ideation, were independently compared by suicide attempt group, BDI item 9 was mea-sured significantly higher in the suicide attempt group than in the suicide attempt group, but HAMD item 3 showed no significant difference between groups.

Suicide attempters show low serotonin activity [16,17], which is consistent with the results of the present study. In a previous study, the investigators compared the LDAEPs of patients with and without a history of suicide attempts and observed that the LDAEP of patients with a history of suicide attempts was higher than that of patients without a history of suicide attempts [18]. Similarly, the investigators in another study observed that among patients with depression, patients with a history of suicide attempts had higher LDAEPs than those without a history of suicide attempts. Still, the number of participants included in the study was relatively small [19].

As discussed previously, the use of LDAEPs for the prediction of suicide is controversial. A small study (n = 16 participants) demonstrated that the BSS scores of the participant groups with low and high LDAEPs, which were classified using median LDAEP values, did not differ significantly [20]. In another study of 73 outpatients with depression, the LDAEPs of patients with suicidal ideation did not differ significantly from those of patients without suicidal ideation [21]. In a recent study, the LDAEPs of patients in the suicide attempt and suicidal ideation groups were lower than those of participants in the healthy control group. However, the difference was not significant after clinical variables were controlled [22]. In another study, the LDAEP of the group with a history of suicide attempts (n = 11) did not differ significantly from that of the group without a history of suicide attempts (n = 130) [23]. It should be noted that the number of participants in the group with a history of suicide attempts was smaller than that in the group without a history of suicide attempts.

The consideration of only suicidal ideation for the prediction of suicidality has yielded controversial results. A study on LDAEPs and suicidality in patients with different subtypes of major depressive disorder revealed a signifi-cant negative correlation between LDAEPs and suicidal ideation among patients in the atypical depression group (n = 53), but there was no significant correlation between LDAEPs and suicidal ideation among patients in the non-atypical depression group (n = 68) [24]. In a different study, most patients with acute suicidal ideation had a high LDAEP [25].

It is noteworthy that this tendency of LDAEPs was reversed between the suicide attempt group and the suicidal ideation group in the present study. It is possible that in patients with suicidal ideation only, partial compensation occurs, and serotonin activity is temporarily increased. Conversely, in patients with a history of suicide attempts, compensation is no longer possible and serotonin activity decreases to a level lower than the baseline value [26].

Suicidal ideation was not distinguished from suicide attempt in previous studies on LDAEP and suicidality [27, 28]. Except for one study, other previous studies on LDAEP and suicidality were focused only on suicidal ideation or suicide attempt [22]. Among the studies on suicide attempts and LDAEP, some studies were focused on acute suicide attempts, whereas others included all patients with a history of suicide attempts, regardless of the time when the suicide attempts were made [29]. To avoid this, suicidal ideation and suicide attempts should be properly categorized in future studies, and the timing and methods of previous suicide attempts should be considered as well.

A recent LDAEP study by Uhl et al. [30] was conducted using a more specific methodology. The investigators [30] measured LDAEP 2, 5, 9, and 16 days after a suicide attempt. The results showed that the LDAEP was the highest on day 9. Instability of central serotonin function might have affected the decreased serotonin activity 1 week after the suicide attempt. This finding suggests that the definition of suicidality should be specifically established and evaluated in future LDAEP studies. The definition of suicidality should be based on whether actual suicide attempts were made, the number of suicide attempts made, the method of the suicide attempts, and the timing of the suicide attempts.

LDAEP values are affected by variables such as sex, age, and smoking [31]. This was pointed out as a limitation in previous studies on the correlation between LDAEP and suicidality [27]. This study is meaningful, as it is a large- scale study of the correlation between LDAEPs and suicidality in which demographic factors, such as age and sex, were controlled for.

However, it has some limitations. First, this was a retrospective study. Second, the presence of suicide attempt was defined as a history of any suicide attempt and the timing of LDAEP measurements was not controlled; therefore, there are limitations in predicting LDAEP changes or trends immediately after suicide attempt. Third, although most patients in this study underwent EEG at the time of initial treatment, some patients underwent EEG several weeks after receiving treatment.

In conclusion, the results of this study suggest that suicidal ideation is associated with elevated serotonin activity, while suicide attempt is associated with decreased serotonin activity.

ACKNOWLEDGEMENTS

The authors would like to thank Jo BW, Son JY, and Kim BE for her assistance with data collection.

Funding

This study was supported by a grant from the National Research Foundation of Korea (NRF), funded by the Ministry of Science and ICT (2020R1F1A1073188).

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

Author Contributions

Conceptualization: Young-Min Park. Formal analysis: Youngjun Cho, Miseon Shim. Methodology: Young-Min Park, Seung-Hwan Lee, Youngjun Cho. Software: Miseon Shim, Seung-Hwan Lee. Writing—original draft: Youngjun Cho. Writing—review and editing: Young-Min Park.

Figures
Fig. 1. Correlation of Total BSS score and N1/P2 LDAEP.
BSS, Beck Scale for Suicidal Ideation; LDAEP, loudness dependence of auditory-evoked potential.
Tables

Comparison of baseline demographic data, clinical symptoms and LDAEPs among patients with presence or absence of previous suicide attempts

Variable Group without suicide attempts (n = 173) Group with suicide attempts (n = 48) t pvalue
Age 42.29 ± 14.00 37.10 ± 13.28 2.295 0.023*
Sex (M/F)a 35/138 9/39 0.052 0.82
Previous alcohol consumption (N/Y)a 116/57 16/32 17.761 <0.001**
Total BDI score 25.78 ± 9.75 31.04 ± 9.65 −3.17 0.002**
Total BSS score 10.18 ± 7.91 18.96 ± 8.85 −6.62 <0.0001***
Total HAMD score 25.10 ± 7.81 20.96 ± 7.19 3.31 0.001*
Total HAMA score 23.02 ± 6.20 22.44 ± 5.94 0.584 0.560
N1 LDAEP −0.60 ± 0.70 −0.54 ± 0.61 −0.509 0.611
P2 LDAEP 0.82 ± 0.82 0.72 ± 0.73 0.704 0.482
N1/P2 LDAEP 1.42 ± 0.99 1.27 ± 0.83 0.954 0.341
N1 left LDAEP-sLORETA 0.11 ± 0.20 0.11 ± 0.21 −0.026 0.979
N1 right LDAEP-sLORETA 0.13 ± 0.26 0.11 ± 0.17 0.499 0.618
N1 total LDAEP-sLORETA 0.12 ± 0.19 0.11 ± 0.17 0.318 0.750
P2 left LDAEP-sLORETA 0.03 ± 0.10 0.06 ± 0.14 −1.70 0.090
P2 right LDAEP-sLORETA 0.41 ± 0.10 0.04 ± 0.10 −0.050 0.958
P2 total LDAEP-sLORETA 0.04 ± 0.08 0.05 ± 0.11 −1.066 0.288
N1/P2 left LDAEP-sLORETA 0.06 ± 0.10 0.07 ± 0.12 −0.991 0.323
N1/P2 right LDAEP-sLORETA 0.07 ± 0.11 0.06 ± 0.10 0.290 0.772
N1/P2 total LDAEP-sLORETA 0.06 ± 0.09 0.07 ± 0.09 −0.396 0.692

LDAEPs, loudness dependence of auditory-evoked potentials; BDI, Beck Depression Inventory; BSS, Beck Scale for Suicidal Ideation; HAMD, Hamilton Depression Rating Scale; HAMA, Hamilton Anxiety Rating Scale; sLORETA, standardized low-resolution brain electromagnetic tomography.

aχ2-test.

*p < 0.05, **p < 0.01, ***p < 0.001.

Linear regression analysis for total BSS score

Variable Standard error Coefficient t pvalue
Sex 1.486 0.044 0.662 0.508
History of alcohol consumption 1.215 0.199 2.963 0.003*
N1/P2 LDAEP 0.614 −0.134 −2.015 0.045*

BSS, Beck Scale for Suicidal Ideation; LDAEP, loudness dependence of auditory evoked potential.

*p < 0.05.

Linear regression analysis for P2 total LDAEP-sLORETA

Variable Standard error Coefficient t pvalue
Age 0.000 −0.082 −1.117 0.266
Sex 0.015 0.183 2.556 0.011*
Previous suicide attempts 0.016 0.161 2.037 0.043*
Total BDI score 0.001 −0.207 −2.533 0.012*
Total BSS score 0.001 −0.044 −0.497 0.620
Total HAMA score 0.001 0.041 0.547 0.585

LDAEP, loudness dependence of auditory-evoked potential; sLORETA, standardized low-resolution brain electromagnetic tomography; BDI, Beck Depression Inventory; BSS, Beck Scale for Suicidal Ideation; HAMA, Hamilton Anxiety Rating Scale.

*p < 0.05.

Binary logistic regression analysis for absence or presence of suicide attempts groups

Previous suicide attempt Coefficient Standard error pvalue Exp. coefficient 95% lower CI Exp. coefficient 95% upper CI Exp. coefficient
Age −0.005 0.015 0.746 0.995 0.965 1.026
P2 left LDAEP-sLORETA 4.638 2.239 0.038* 103.29 1.282 8,321.467
Total BSS −0.019 0.075 0.796 0.981 0.847 1.136
Total BDI −0.05 0.045 0.264 0.951 0.872 1.038
Total HAMA −0.077 0.036 0.031* 0.926 0.863 0.993
Sex 0.156 0.566 0.782 1.169 0.386 3.545
Total BSS × Total BDI 0.005 0.003 0.040* 1.005 1.00 1.01

Exp. coefficient, exponentiated coefficient; CI, confidence interval; LDAEP, loudness dependence of auditory-evoked potential; sLORETA, standardized low-resolution brain electromagnetic tomography; BSS, Beck Scale for Suicidal Ideation; BDI, Beck Depression Inventory; HAMA, Hamilton Anxiety Rating Scale.

*p < 0.05.

References
  1. World Health Organization (WHO). Suicide worldwide in 2019. Global health estimates [Internet]. WHO; 2021 Jun 16 [cited at 2023 Dec]. Available from: https://www.who.int/publications/i/item/9789240026643.
  2. Schildkraut JJ. The catecholamine hypothesis of affective disorders: A review of supporting evidence. 1965. J Neuropsy-chiatry Clin Neurosci 1995;7:524-533; discussion 523-524.
    Pubmed CrossRef
  3. Asberg M, Nordström P, Träskman-Bendz L. Cerebrospinal fluid studies in suicide. An overview. Ann N Y Acad Sci 1986;487:243-255.
    Pubmed CrossRef
  4. O'Neill BV, Croft RJ, Nathan PJ. The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: Rationale, evaluation and review of findings. Hum Psychopharmacol 2008;23:355-370.
    Pubmed CrossRef
  5. Linka T, Müller BW, Bender S, Sartory G, Gastpar M. The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depres-sion. Pharmacopsychiatry 2005;38:139-143.
    Pubmed CrossRef
  6. Linka T, Müller BW, Bender S, Sartory G. The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression. Neurosci Lett 2004;367:375-378.
    Pubmed CrossRef
  7. Juckel G, Pogarell O, Augustin H, Mulert C, Müller-Siecheneder F, Frodl T, et al. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry 2007;68:1206-1212.
    Pubmed CrossRef
  8. Park YM, Kim DW, Kim S, Im CH, Lee SH. The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder. Psychopharmacology (Berl) 2011;213:625-632.
    Pubmed CrossRef
  9. Ernst C, Mechawar N, Turecki G. Suicide neurobiology. Prog Neurobiol 2009;89:315-333.
    Pubmed CrossRef
  10. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
    Pubmed CrossRef
  11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
    Pubmed KoreaMed CrossRef
  12. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 1995;51:768-774.
    Pubmed CrossRef
  13. Maier W, Buller R, Philipp M, Heuser I. The Hamilton anxiety scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord 1988;14:61-68.
    Pubmed CrossRef
  14. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: The scale for suicide ideation. J Consult Clin Psychol 1979;47:343-352.
    Pubmed CrossRef
  15. Pascual-Marqui RD. Standardized low-resolution brain electromagnetic tomography (sLORETA): Technical details. Methods Find Exp Clin Pharmacol 2002;24 Suppl D:5-12.
    Pubmed
  16. Lester D. The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: A meta-analysis. Pharmacopsychiatry 1995;28:45-50.
    Pubmed CrossRef
  17. Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP. Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharmacol 2006;9:465-474. Erratum in: Int J Neuropsychopharmacol 2006;9:777.
    Pubmed CrossRef
  18. Kim DH, Park YM. The association between suicidality and serotonergic dysfunction in depressed patients. J Affect Disord 2013;148:72-76.
    Pubmed CrossRef
  19. Chen TJ, Yu YW, Chen MC, Wang SY, Tsai SJ, Lee TW. Serotonin dysfunction and suicide attempts in major depressives: An auditory event-related potential study. Neuropsy-chobiology 2005;52:28-36.
    Pubmed CrossRef
  20. Park YM, Lee BH, Um TH, Kim S. Serum BDNF levels in relation to illness severity, suicide attempts, and central serotonin activity in patients with major depressive disorder: a pilot study. PLoS One 2014;9:e91061.
    Pubmed KoreaMed CrossRef
  21. Park YM, Lee BH, Lee SH. The association between serum lipid levels, suicide ideation, and central serotonergic activity in patients with major depressive disorder. J Affect Disord 2014;159:62-65.
    Pubmed CrossRef
  22. Kim JS, Kim S, Lee HS, Kwon YJ, Lee HY, Shim SH. Auditory evoked potentials and suicidal behaviors in patients with major depressive disorders. Sci Rep 2021;11:7255.
    Pubmed KoreaMed CrossRef
  23. Min JA, Lee SH, Lee SY, Chae JH, Lee CU, Park YM, et al. Clinical characteristics associated with different strengths of loudness dependence of auditory evoked potentials (LDAEP) in major depressive disorder. Psychiatry Res 2012;200:374-381.
    Pubmed CrossRef
  24. Lee SH, Park YC, Yoon S, Kim JI, Hahn SW. Clinical implications of loudness dependence of auditory evoked potentials in patients with atypical depression. Prog Neuropsychopharmacol Biol Psychiatry 2014;54:7-12.
    Pubmed CrossRef
  25. Juckel G, Hegerl U. Evoked potentials, serotonin, and suicidality. Pharmacopsychiatry 1994;27 Suppl 1:27-9.
    Pubmed CrossRef
  26. DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005;62:409-416.
    Pubmed CrossRef
  27. Graßnickel V, Illes F, Juckel G, Uhl I. Loudness dependence of auditory evoked potentials (LDAEP) in clinical monitoring of suicidal patients with major depression in comparison with non-suicidal depressed patients and healthy volunteers: a follow-up-study. J Affect Disord 2015;184:299-304.
    Pubmed CrossRef
  28. Hwang M, Lee YJ, Lee M, Kang B, Lee YS, Hwang J, et al. Relationship between the loudness dependence of the auditory evoked potential and the severity of suicidal ideation in patients with major depressive disorder. Clin Psychopharmacol Neurosci 2021;19:323-333.
    Pubmed KoreaMed CrossRef
  29. Park YM. Relationship between serotonergic dysfunction based on loudness dependence of auditory-evoked potentials and suicide in patients with major depressive disorder. Psychiatry Investig 2015;12:421-424.
    Pubmed KoreaMed CrossRef
  30. Uhl I, Illes F, Graßnickel V, Echterhoff S, Norra C, Juckel G. Loudness dependence of auditory evoked potentials (LDAEP) in clinical monitoring of suicidal patients with major depression: A pilot study. Eur Arch Psychiatry Clin Neurosci 2012;262:487-492.
    Pubmed CrossRef
  31. Park YM, Lee SH. Can the loudness dependence of auditory evoked potentials and suicidality be used to differentiate between depressive patients with and without bipolarity. Psychiatry Investig 2013;10:143-147.
    Pubmed KoreaMed CrossRef


This Article

Close ✕


Cited By Articles

Author ORCID Information

Funding Information

Services
Social Network Service

e-submission

Archives